Search

An editorial is presented on the digital technologies adopted by the Inertia Pharma. It explains the impact of digital technologies in the production outcome of the industry. An overview of the new drugs introduced in the Indian Pharmaceutical market and their digital marketing programs is presented.

The author reflects on the model of partnerships adopted by India's pharmaceutical industry that is expected to benefit all stakeholders. Topics include the move by companies like Biocon, Zydus and Aurobindo to partner with research institutes and universities like the Indian Institute of Chemical Technology (IICT), and the recommended inclusion of retired research professionals in public-private research projects.

The article focuses on the PARTNERSHIPS BETWEEN INDUSTRY AND INSTITUTES/ACADEMIA . Topics discussed include Venture Centre, Pune is a technology business incubator specializing in promoting technology start-ups offering products and services exploiting scientific expertise in the area of materials, chemicals, biological sciences & engineering; and few exceptional achievements of this innovation/start up incubation Venture Centre are worth mentioning her.

The article focuses on the repurposing of the drugs have emerged as the most potent strategy to treat Covid-19. It mentions the current crisis has created more awareness on the need for strong immunity building to prevent or avoid co-morbities. It also mentions that aspirin has been in use for hundreds of years to treat inflammation.

The article offers information related to the contribution of India in pharmacy of the world. It mentions about works of Doctor Ram Nath Chopra, the father of Indian Pharmacology; and Doctor M.L. Shroff who started the first Pharmacy course at Banaras Hindu University in India in 1932. It also mentions about books and publications on Indian Herbal resources and their medicinal applications including "British Herbal Pharmacopoeia," and "Ayurvedic Pharmacopoeia of India,.